hypoglycaemia

This page shows the latest hypoglycaemia news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk spends $800m on biotech and 'glucose responsive insulin' tech

Combining this technology with Novo Nordisk’s insulin to create GRIs would ultimately help further its goal of eliminating the risk of hypoglycaemia, the main risk associated with insulin therapy. ... have the potential to lead to the development of

Latest news

FDA starts review of Sanofi’s oral type 1 diabetes drug

The results suggest adding the drug to insulin therapy can improve glucose control as measured by haemoglobin A1c levels, with a reduced risk of potentially dangerous low blood sugar levels (hypoglycaemia).
Novo says real-world data backs its insulin switching

Rates of overall hypoglycaemia were also significantly lower after switching to Tresiba, falling 85% in type 1 and 92% in type 2 patients at six months. ... compare the two drugs on not only glucose control and hypoglycaemia but also cardiovascular
Novo Nordisk's long-acting haemophilia B drug cleared by FDA

likely to cause low blood sugar levels or hypoglycaemia in patients with type 2 diabetes compared to Sanofi's Lantus.
Novo seeks to strengthen Tresiba label in US

An earlier study - called SWITCH 2 - also found an advantage for Tresiba over Lantus on hypoglycaemia rates. ... The risk of severe hypoglycaemia is a major cause for people with type 2 diabetes not reaching their treatment targets," said Mads Krogsgaard
AstraZeneca's Forxiga set to be recommended by NICE

dose in combination with either metformin or insulin for patients unable to take sulphonylurea medicines or at significant risk of hypoglycaemia.

More from news
Approximately 2 fully matching, plus 94 partially matching documents found.

Latest Intelligence

Interview: Peter Meeus, Novo Nordisk

end of last year and has demonstrated it is as effective in reducing blood glucose levels as is its rival Lantus from Sanofi, yet carries less risk of hypoglycaemia. ... In addition, Meeus highlighted a need to raise awareness among the healthcare
Interview: Pierre Chancel, Sanofi Diabetes

2 diabetes further reduce HbA1c, with the benefit of weight loss and limited risk of hypoglycaemia.”.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

How technology is shaping patient education

The simulation showed the high impact of mild hypoglycaemia (low blood sugar) on a patient; it made the viewer ‘ feel’ the symptoms of hypoglycaemia in various scenarios through a typical day

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director: Competitive Salary Offered

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Healthcare Communications Account Directors x 2: Salary TBC

Account Executive/ Senior Account Executive: competitive Salary Offfered

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Senior Editorial Assistant – Greater Manchester: DOE

Business Development Director – Health Education: excellent commission

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Manager: Negotiable

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

Senior Account Manager: Competitive Salary Offered

Business Director: Competitive Salary Offered

Medical (Scientific) Director: £120, 000 benefits

Principal Health Economist - North-West: Negotiable

Account Manager / Account Director: Competative

Account Manager / Senior Account Manager: 35, 000-40, 000

Subscribe to our email news alerts

PMHub

Add my company

Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?: What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma: Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies: Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...